Global $392.80 Billion Nanomedicine Market Drivers, Opportunities, Trends, and Forecasts, 2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Nanomedicine Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.

The Nanomedicine Market to Grow at a CAGR of 17.1% During the Forecast Period 2017-2023 to Aggregate $392.80 Billion By 2023.

The nanomedicine market is analyzed based on two segments - therapeutic applications and regions.

The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.

Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be used effectively as conventional oral formulations due to poor bioavailability. The therapeutic areas for nanomedicine application are Oncology, Cardiovascular, Neurology, Anti-inflammatory, Anti-infectives, and various other areas.

Globally, the industry players are focusing significantly on R&D to gain approval for various clinical trials for future nano-drugs to be commercially available in the market. The FDA should be relatively prepared for some of the earliest and most basic applications of nanomedicine in areas such as gene therapy and tissue engineering. The more advanced applications of nanomedicine will pose unique challenges in terms of classification and maintenance of scientific expertise.

Market Dynamics

Drivers

  • Emergence of nanorobotics
  • Applications and advantages of nanomedicine in various healthcare segments
  • Reasonable investments in R&D
  • Increased support from governments

Restraints

  • Long approval process and stringent regulations
  • Problems regarding nanoscale manufacturing
  • Risks related to nanomedicines
  • Undefined regulatory standards

Opportunities

  • Aging population with chronic care needs
  • Population and income growth in emerging countries

Key Players:

  • Merck & Co. Inc.
  • Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • Novartis AG
  • Amgen Inc
  • Pfizer Inc.
  • Eli Lilly and Company
  • Sanofi
  • Nanobiotix SA
  • UCB SA

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outlook

5 Market Characteristics

6 Trends, Roadmap and Projects

7 Types: Market Size and Analysis

8 Trending Nanomedicines

9 Regions: Market Size and Analysis

10 Vendor Scenario

11 Vendor Profiles

12 Global Generalist

13 Companies to Watch for

14 Market Landscape

For more information about this report visit http://www.researchandmarkets.com/research/2bv34j/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nanotechnology, Nanomedicine

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nanotechnology, Nanomedicine